We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use

By LabMedica International staff writers
Posted on 02 Apr 2024

A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and FDA clearance for use with critically ill patients. More...

Nova Biomedical (Waltham, MA, USA) has introduced the New Generation StatStrip Glucose Hospital Meter System to the U.S. market. This system continues to utilize the only FDA-cleared test strip for glucose testing of critically ill patients. More than 200 published clinical studies validate StatStrip's accurate and reliable results, highlighting its ability to eliminate interference from a wide range of medications (over 8,000 tested) and the complex physiological conditions often encountered among patients in intensive care settings with complex medical conditions and drug regimens. The New Generation StatStrip enhances bedside glucose testing with several key advancements, including a transition to a Linux® operating system for improved cybersecurity against viruses and other malware, and extension of its hematocrit range to 5-75%.

The New Generation StatStrip now comes with RFID technology, an illuminated barcode scanner, and touchscreen keyboard entry for easier submission of operator ID and patient ID. It also features a wireless meter for faster, easier, and safer charging. The battery is charged in the meter’s sealed compartment, with the charger automatically shutting off when the meter becomes fully charged. Additionally, StatStrip’s new meter casing has been built using a unique soft-touch over-molding material that can withstand rough use and exposure to harsh disinfecting agents.

“We are proud to now offer our StatStrip New Generation platform for glucose testing,” said Rick Rollins, StatStrip Product Manager. “The new meter gives current StatStrip users and non-users a clear upgrade for easier hospital glucose testing while ensuring accurate, interference- free, and safe use with critically ill patients.”

Related Links:
Nova Biomedical


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
mRNA Extraction Kits
TurboCapture mRNA Kits
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.